Logo
Nazad
D. Roos, D. Kuhns, A. Maddalena, J. Roesler, Juan A. López, T. Ariga, T. Avčin, M. de Boer, J. Bustamante, A. Condino-Neto, G. Di Matteo, Jianxin He, H. Hill, S. Holland, C. Kannengiesser, Mustafa Yavuz Köker, I. Kondratenko, K. van Leeuwen, H. Malech, L. Maródi, H. Nunoi, M. Stasia, A. Ventura, Carl T Witwer, B. Wolach, J. Gallin
248 1. 12. 1997.

Hematologically important mutations: X-linked chronic granulomatous disease (third update)

Chronic Granulomatous Disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase. Superoxide is used to kill phagocytosed micro-organisms in neutrophils, eosinophils, monocytes and macrophages. The leukocyte NADPH oxidase is composed of five subunits, of which the enzymatic component is gp91-phox, also called Nox2. This protein is encoded by the CYBB gene on the × chromosome. Mutations in this gene are found in about 70% of all CGD patients. This article lists all mutations identified in CYBB in the X-linked form of CGD. Moreover, apparently benign polymorphisms in CYBB are also given, which should facilitate the recognition of future disease-causing mutations.


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više